Retinoic Acid Receptor Responder (Tazarotene Induced) 1 Proteins (RARRES1)

RARRES1 was identified as a retinoid acid (RA) receptor-responsive gene. Additionally we are shipping RARRES1 Antibodies (62) and RARRES1 Kits (4) and many more products for this protein.

list all proteins Gene Name GeneID UniProt
Mouse RARRES1 RARRES1 109222  
Rat RARRES1 RARRES1 310486  
RARRES1 5918 P49788
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top RARRES1 Proteins at

Showing 5 out of 10 products:

Catalog No. Origin Source Conjugate Images Quantity Delivery Price Details
Insect Cells Human His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg 50 Days
Escherichia coli (E. coli) Human His tag 100 μg 13 to 16 Days
Wheat germ Human GST tag 10 μg 11 to 12 Days
Escherichia coli (E. coli) Human Un-conjugated SDS-PAGE analysis of Human RARRES1 Protein. 100 μg 11 to 18 Days
Yeast Chicken His tag   1 mg 60 to 71 Days

RARRES1 Proteins by Origin and Source

Origin Expressed in Conjugate
Human , ,
, , ,

More Proteins for Retinoic Acid Receptor Responder (Tazarotene Induced) 1 (RARRES1) Interaction Partners

Human Retinoic Acid Receptor Responder (Tazarotene Induced) 1 (RARRES1) interaction partners

  1. Study demonstrates that RARRES1 depletion in epithelial cells caused a global increase in lipid synthesis. RARRES1-depleted cells rewire glucose metabolism by switching from aerobic glycolysis to glucose-dependent de novo lipogenesis. Treatment with fatty acid synthase inhibitor reversed the effects of RARRES1 depletion.

  2. TIG1 interacted with DNAJC8 in the cytosol, and this interaction completely blocked DNAJC8-mediated PKM2 translocation and inhibited glucose uptake. Furthermore, increased glycose uptake was observed in cells in which TIG1 was silenced.

  3. Data demonstrated that RARRES1 expression is lost in choriocarcinoma tumors due to promotor hypermethylation. Also, further results hypothesized that RARRES1 might be a negative regulator of EMT through induction of contact inhibition.

  4. Data show that retinoic acid receptor responder 1 (RARRES1) expression is subtype-dependent and regulated by DNA methylation and the expression of aldehyde dehydrogenase 1A3 (ALDH1A3).

  5. Data suggest that Retinoic Acid Receptor Responder (RARRES1)/ Tazarotene-induced gene-1 (TIG-1) may serve as a target for therapeutic intervention both in cancer and in angiogenesis-related disorders.

  6. Authors found that transmembrane protein 192 (TMEM192) interacted with TIG1. Authors also found that both TIG1A and TIG1B isoforms interacted and co-localized with TMEM192 in HtTA cervical cancer cells. The expression of TIG1 induced the expression of autophagy-related proteins.

  7. All-trans retinoic acid modulated secretion of RARRES1 in a dose dependent manner.

  8. our data suggested that epigenetic silencing of TIG1 gene expression by promoter hypermethylation may play an important role in hepatocellular carcinoma .

  9. High TIG1 expression is associated with inflammatory breast cancer through activation of Axl kinase.

  10. Analysis of a standard liver fibrosis model (CCl(4)) demonstrated an early induction of RARRES1 mRNA and protein expression.

  11. genotype-associated hypermethylation of the ETS-family target gene RARRES1 influences methylation at its neighbor gene LXN and could be useful as a prognostic biomarker.

  12. Knocking-down CTCF expression hampered RARRES1 expression.

  13. TIG1 suppressed PGE2-stimulated Wnt and cAMP signaling pathways in colon cancer cells through GRK5.

  14. GRK5 mediates cell growth suppression by TIG1A. Thus, TIG1 may participate in the downregulation of G-protein coupled signaling by upregulating GRK5 expression.

  15. The results of this study suggested that short RAI1 alleles might be releated to schizophreina disease.

  16. RARRES1, its interacting partners AGBL2, Eg5/KIF11, another EEY-bearing protein (EB1), and the microtubule tyrosination cycle are important in tumorigenesis.

  17. Silencing of TIG1 promoter by hypermethylation is common in human cancers and may contribute to the loss of retinoic acid responsiveness in some neoplastic cells.

  18. results show that inactivation of the retinoic acid signaling-associated genes RAR-beta, CRBP1, and TIG1 by DNA methylation occurs frequently in esophageal squamous cell carcinoma

  19. Hypermethylation of tazarotene-induced gene 1 is associated with gastric carcinogenesis

  20. TIG1 overexpression in SASC inhibited their differentiation into osteocytes and the expression of osteocalcin

RARRES1 Protein Profile

Protein Summary

This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Alternatively spliced transcript variant encoding distinct isoforms have been observed.

Gene names and symbols associated with RARRES1

  • retinoic acid receptor responder (tazarotene induced) 1 (Rarres1)
  • retinoic acid receptor responder 1 (Rarres1)
  • retinoic acid receptor responder (tazarotene induced) 1 L homeolog (rarres1.L)
  • retinoic acid receptor responder 1 (RARRES1)
  • 5430417P09Rik protein
  • AI662122 protein
  • LXNL protein
  • MGC68628 protein
  • OCX32 protein
  • RARRES1 protein
  • TIG1 protein

Protein level used designations for RARRES1

tazarotene-induced protein 1 , retinoic acid receptor responder (tazarotene induced) 1 , retinoic acid receptor responder protein 1 , ovocalyxin 32 , RAR-responsive protein TIG1 , latexin-like , tazarotene-induced gene 1 protein , 32 kDa eggshell matrix protein , OCX-32 , ovocalyxin-32

109222 Mus musculus
310486 Rattus norvegicus
398803 Xenopus laevis
510102 Bos taurus
741650 Pan troglodytes
100232262 Taeniopygia guttata
5918 Homo sapiens
395209 Gallus gallus
Selected quality suppliers for RARRES1 Proteins (RARRES1)
Did you look for something else?